Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
07/2004
07/01/2004WO2002100341A3 Compounds for the treatment of metabolic disorders
07/01/2004US20040127740 3, 4-disubstituted pyridine compounds;
07/01/2004US20040127706 activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4; useful for treating diseases whose symptoms and or damage are related to binding of VCAM-1 to cells expressing VLA-4 such as rheumatoid arthritis, multiple sclerosis
07/01/2004US20040127574 Aminoethanol derivatives
07/01/2004US20040127555 bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; treatment of A beta , IAPP, other amyloids, and alpha -synuclein or NAC fibrillogenesis
07/01/2004US20040127533 Sulfonamide derivatives
07/01/2004US20040127506 Antimycobacterial compounds
07/01/2004US20040127495 Preferential suppressors of immunoglobulins, used as immunosuppressants and antiallergens
07/01/2004US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome
07/01/2004US20040127487 For therapy and prophylaxis of bone diseases, cancer, systemic granuloma, immunological diseases, allergy, atopy, asthma, gumboil, gingivitis, periodontitis, neurocyte death, Alzheimer's diseases, lungs injury, pulmopathy, acute hepatitis
07/01/2004US20040127477 Heterocyclic glycyl beta-alanine derivatives
07/01/2004US20040127467 Synthesis of pancratistatin prodrugs
07/01/2004US20040127464 potent, selective and safe inhibitors of the Ca2+-activated potassium channel
07/01/2004US20040127382 activity of peroxy compounds in washing, bleaching and cleaning processes at low temperature is increased by the transition metal complexes
07/01/2004US20040123403 Disazo or azo dyes; mixture with ultraviolet radiation absorber
07/01/2004DE10261091A1 Gesättigte und ungesättigte Heteroarylcycloalkylmethyl-Amine Saturated and unsaturated amines Heteroarylcycloalkylmethyl
07/01/2004DE10260879A1 Mittel zum Färben von keratinhaltigen Fasern Formulations for coloring keratin-containing fibers
07/01/2004CA2510322A1 2-pyridyl and 2-pyrimidyl cycloalkylene amide compounds as nr2b receptor antagonists
07/01/2004CA2509244A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
06/2004
06/30/2004EP1434286A1 Phenyl pyridine-iridium metal complex compounds for organic electroluminescent device, process for preparing the compounds, and organic electroluminescent device using the compounds
06/30/2004EP1433840A1 Composition and method for bleaching a substrate
06/30/2004EP1433785A1 Agents for the coloration of keratinous fibres
06/30/2004EP1433784A1 Process for the synthesis of torsemide, in particular of pure and stable form II
06/30/2004EP1433468A1 N-Methyl quinolinium imines used for dyeing keratin containing fibres
06/30/2004EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
06/30/2004EP1432685A1 Crystalline hydrates of nicotinic acid anilide and benzoyl anilide derivatives
06/30/2004EP1432684A2 Pyridinic sulfonamide derivatives, method of production and use thereof
06/30/2004EP1432453A1 Stilbene derivatives and their use for binding and imaging amyloid plaques
06/30/2004EP1432424A1 Heterocyclic substituted 2- (4-phenoxy) pyridine derivatives and related compounds as sodium channel blockers for the treatment of neuronal damage and neurodegenerative conditions
06/30/2004EP1432419A1 Aryl substituted pyridinecarboxamides and their use as sodium channel blockers
06/30/2004EP1432394A1 Agent for coloring keratin fibers
06/30/2004EP1432313A1 N-thio-nicotinamide derivatives and related compounds for use as pesticides
06/30/2004EP1070049B1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
06/30/2004EP1037880B1 Retinoic acid mimetic anilides
06/30/2004EP0975596B1 Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors
06/30/2004CN1509285A Substituted aryl ketons
06/30/2004CN1509283A Novel pyridyl cyanoguandine compounds
06/30/2004CN1509278A N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound
06/30/2004CN1509269A 磺酰胺衍生物 Sulfonamide derivatives
06/30/2004CN1509268A Substituted aromatic amide derivative intemediate thereof, agrohorticultral insecticide containing thereof and method for use thereof
06/30/2004CN1509267A Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II
06/30/2004CN1155618C PEG-interferon conjugates
06/30/2004CN1155575C Production process of heterocyclic nitrile
06/30/2004CN1155562C New naphthalene compounds, process for their preparation and pharmaceutical compositions containing them
06/29/2004US6756497 Benzoic acid derivatives and processes for the preparation thereof
06/29/2004US6756392 Carbocyclic secondary amides such as 2-(4-fluoro-phenoxy) -n-(4-((2-hydroxy-3-methyl-benzoyl amino)-methyl)-benzyl)-nicotinamide, administered for prophylaxis of respiratory system disorders
06/29/2004US6756380 5-phenyl-pyrimidine derivatives
06/29/2004US6756378 VLA-4 inhibitor compounds
06/29/2004US6756216 Batch processing using nucleophilic compound
06/24/2004WO2004052890A1 Heterocyclic compounds, methods of making them and their use in therapy
06/24/2004WO2004052884A1 Anthranilic acid amide derivatives and their pharmaceutical use
06/24/2004WO2004052880A1 Pyridine derivatives as jnk inhibitors and their use
06/24/2004WO2004052872A1 Haloalkene compounds, process for their production and pesticides containing them
06/24/2004WO2004052869A1 5-substituted-pyrazine or pyridine glucokinase activators
06/24/2004WO2004052861A1 Hydroxyalkylated cyclic diamine compound
06/24/2004WO2004052860A1 Method for photochemical halogenation
06/24/2004WO2004052859A1 Erythropoietin production accelerator
06/24/2004WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators
06/24/2004WO2004052844A1 Prodrugs of gaba analogs, compositions and uses thereof
06/24/2004WO2004052841A1 Carbidopa prodrugs and uses thereof
06/24/2004WO2004052838A1 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents
06/24/2004WO2004052830A1 Chiral arylketones in the treatement of neutrophil-dependent inflammatory deseases
06/24/2004WO2004052816A1 Dihalo-allyloxy-phenol derivatives having pesticidal activity
06/24/2004WO2004052291A2 Pyridines for treating injured mammalian nerve tissue
06/24/2004WO2004052280A2 Anti-angiogenic compounds and their use in cancer treatment
06/24/2004WO2004033430A3 Process for production of fluoroalkoxy-substituted benzamides and their intermediates
06/24/2004WO2004005288A3 Charge transport compositions comprising fluorinated phenanthroline derivatives
06/24/2004WO2004002925A3 Process for preparing (r)-aryloxypropionic acid ester derivatives
06/24/2004WO2003090690A3 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
06/24/2004WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/24/2004US20040122247 Substituted pyridyl amine catalysts and processes for polymerizing crystalline polymers
06/24/2004US20040122235 such as N-(2-Phenoxyphenyl)-N'-(thiazol-2-yl)urea; for treating diseases in which increasing glucokinase activity is beneficial (diabetes)
06/24/2004US20040122219 Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same
06/24/2004US20040122102 compounds are potent ocular hypotensives, and are suitable for the management of glaucoma; they also are smooth muscle relaxants with broad application in systemic hypertensive and pulmonary diseases, gastrointestinal, reproduction disorders etc
06/24/2004US20040122061 Inhibitors of post-amadori advanced glycation end products
06/24/2004US20040122057 Novel mandelic acid derivatives
06/24/2004US20040122055 C10 carbonate taxane compositions
06/24/2004US20040122050 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
06/24/2004US20040122017 Melanin concentrating hormone (MCH) modulators; metabolic and eating disorders
06/24/2004US20040122007 1-aryl-2-hydroxyethyl amides as potassium channel openers
06/24/2004US20040122004 such as (1R,2R)-N-[(1S)-2-amino-1-(4-fluorophenyl)-2-oxoethyl]-2-(4-{[{[ethyl(2-hydroxyethyl)amino]carbonyl}(4-fluorophenyl)amino]methyl}phenyl)cyclohexanecarboxamide; for prevention/treatment of cardiovascular disorders
06/24/2004US20040121997 20-hydroxyeicosatetraenoic acid production inhibitors
06/24/2004US20040121995 such as trifluoromethanesulfonic acid, N-[4-(2,5-difluorophenyl)-4-(6-trifluoromethyl-pyridine-3-sulfonyl)-cyclohexyl]-amide; for treatment/prevention of Alzheimer's disease
06/24/2004US20040121994 Novel amides that activate soluble guanylate cyclase
06/24/2004US20040121947 Compounds which inhibit beta-secretase activity and methods of use thereof
06/24/2004US20040121316 Method and compositions for identifying anti-HIV therapeutic compounds
06/24/2004DE10258695A1 New 2-(2-hydroxy-2-(3-methylsulfonylamino-4-hydroxyphenyl)ethylamino-4-(pyrid-2-ylamino)-2-methylbutane used e.g. for treating asthma and chronic obstructive pulmonary disease
06/24/2004DE10258671A1 New bis(trifluoromethyl)amide salts of cationic heterocyles, useful e.g. as ionic liquids and as intermediates for pharmaceuticals and plant-protection agents
06/24/2004DE10258314A1 New alkoxyimino-substituted biphenylcarboxamide derivatives, useful as pesticides, antimicrobials, herbicides and antimycotics, also their new intermediates
06/24/2004DE10256999A1 Production of halogenated compounds, especially chlorinated picoline, lutidine and collidine, involves photohalogenation in presence of an acid, e.g. trifluoroacetic acid, which prevents formation of hydrogen halide adducts
06/24/2004CA2508792A1 Heterocyclic compounds, methods of making them and their use in therapy
06/24/2004CA2508165A1 Pyridines for treating injured mammalian nerve tissue
06/24/2004CA2507137A1 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents
06/24/2004CA2506164A1 Anthranilic acid amide derivatives and their pharmaceutical use
06/23/2004EP1431289A2 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
06/23/2004EP1431288A2 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
06/23/2004EP1431285A1 Reverse hydroxamic acid derivatives
06/23/2004EP1430057A2 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives
06/23/2004EP1430041A2 Novel sulfonic acid derivatives
06/23/2004EP1430023A1 Substituied urea retinoid agonists ii